FREMONT, Calif., Feb. 20, 2025 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of its Certified ...
10don MSN
Seattle’s Alpenglow moves 3D microscope tech from lab to clinic to help modernize cancer diagnostics
Alpenglow Biosciences announced a partnership with PathNet to help commercialize use of the startup's 3D microscope ...
ANN ARBOR, Mich., Nov. 19, 2024 /PRNewswire/ -- Ambient Biosciences, a pioneering life science company, today announced the launch of its Early Access Program (EAP), seeking partners to trial their ...
Nanosecond PFA 360° Cardiac Catheter for AF ablation to be highlighted in presentations and in a live case transmission “We are gaining significant momentum generating clinical and preclinical ...
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced ...
Tiger BioSciences, a leader in regenerative medicine and tissue innovation, today announced the acquisition of Platelet-Rich ...
The parking lot that once held the New Haven Veterans Memorial Coliseum will soon become a bioscience technology hub. The former sports and entertainment arena opened in 1972, closed in 2002 and was ...
Twist Bioscience has seen significant share price growth in the past year, driven by innovative DNA synthesis technology and strong revenue growth. Despite challenges in the life sciences industry, ...
Geneva, Switzerland and Boston, MA – July 1, 2020 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN - a clinical-stage biopharmaceutical company focused on the development and commercialization of novel ...
San Francisco, March 14, 2023 (GLOBE NEWSWIRE) -- SAN FRANCISCO, March 14, 2023 (GLOBE NEWSWIRE) – Culture Biosciences today announced that it is increasing its focus on upstream bioprocess ...
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA ...
One Biosciences Announces EUR15 Million Series A Financing to Advance Clinical Single Cell Profiling
The MarketWatch News Department was not involved in the creation of this content. -- Funding will be used to establish the clinical utility of OneMap(TM), a proprietary artificial intelligence (AI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback